Goodwin Procter LLP advised Aura Biosciences on the deal.Aura Biosciences announced the closing of its oversubscribed $80 million financing. The financing was led by Matrix Capital Management…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
